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Surgical treatment in patients with severe acute pancreatitis is still a controver-
sial subject, ranging from sole conservative to an aggressive approach. This arti-
cle gives an overview ofthe literature with regard to indications for surgery, tim-
ing and techniques of operative treatment concepts in severe acute pancreatitis
with special attention to the recommended necrosectomy and closed continuous
lavage of the involved retroperitoneum. Taking into account recent findings
from microbiological data we have developed a new algorithm in patients with
acute pancreatitis. All patients with proven acute necrotizing pancreatitis
receive an antibiotic therapy for 2 weeks beside the intensive care measures. So
far only one third (33 percent) had infected pancreatic necroses in the 3rd week
of the onset of the disease and were managed surgically. The delay resulted in
optimal surgical conditions for necrosectomy and a mortality rate of 9 percent.
This new concept and therapeutic approach with the early suitable antibiotic
therapy in patients with proven necrotizing pancreatitis is recommended to (1)
decrease the infection rate and (2) delay surgical intervention to the 3rd week of
the disease with optimal surgical conditions. It seems that only patients with
proven infected pancreatic necroses are candidates for surgical intervention.
INTRODUCTION
Acute pancreatitis can be classified histologically as interstitial-edematous or necro-
tizing inflammation ofthe pancreatic gland, and the clinical course in patients with acute
pancreatitis varies from a mild, transitory illness to a rapidly fatal disease [1, 2]. Clinical
and experimental observations have shown that in the early stage ofsevere acute pancrea-
titis biologically active compounds are released into ascitic fluids and systemic circulation
[3, 4]. Patients who die within the first week due to necrotizing pancreatitis suffer cardio-
vascular, pulmonary, and renal complications which determine the clinical course.
Because of improvement in intensive care therapy, and particularly with the early central
venous pressure-adjusted fluid replacement, hardly any patient with acute pancreatitis dies
within this early phase of the disease. Septic complications prevail in the later stage of
necrotizing pancreatitis, and, nowadays, local and systemic septic complications are the
most frequent cause of death in severe acute pancreatitis [5, 6, 7].
Clinical management of acute pancreatitis is based on the observation that most
patients have a mild, self-limiting disease [8]. However, there are appreciable uncertain-
ties with regard to the therapeutic schedule, since specific and effective pharmacotherapy
is not available, and the effectiveness of surgical treatment of necrotizing pancreatitis has
so far not been substantiated by controlled prospective clinical data. Undoubtedly, in
patients with acute pancreatitis and local septic complications following bacterial infec-
tion of necrotic material, surgical therapy has proved superior to the conservative treat-
ment in the past [8, 9].
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The goals of surgical management of necrotizing pancreatitis are removal of necrot-
ic peri- and intrapancreatic tissue, removal ofpancreatogenic exudate out ofthe lesser sac
and the peritoneal cavity with the aim of preventing systemic release of vasoactive and
toxic substances. A further very important step ofoperative therapy is the preservation of
intact vital pancreatic tissue. The need for this is based on the experience that, macro-
morphologically, the necrotizing process is often represented mainly by fatty tissue
necroses in and around the vital exocrine and endocrine pancreatic parenchyma [10, 11].
In the past, a variety of surgical treatment modalities (Table 1) has been propagated,
including pancreatic resection [12, 13, 14], peritoneal dialysis [15, 16, 17], multiple tube
drainage [18], surgical debridement and suction drainage [9, 19], necrosectomy supple-
mented with different postoperative treatment concepts, such as continuous local lavage
of the necrotic cavities [4, 20], planned, staged relaparotomy [21] or the open packing
modality [22], and nonoperative drainage using percutaneous techniques [23, 24].
However, you may have to keep in mind that the results of surgical treatment of necrotiz-
ing pancreatitis depend not only on the surgical technique used, but also on the patient
group, the severity of concomitant morbidity factors, timing of surgical intervention,
extent of the necrotizing process and most important by one the bacterial infection of
necroses [5].
Table 1. Acute necrotizing pancreatitis: surgical management protocols.
Protocol Remarks
Nonoperative drainage procedures Not effective enough to remove pancreatic
necroses
Pancreatic resection Overtreatment
Peritoneal dialysis No effect on the retroperitoneal process
Triple-tube drainage
Necrosectomy + closed lesser sac lavage
Necrosectomy + open packing In experienced hands good results
Necrosectomy + planned, staged relaparotomy
INDICATION FOR SURGICAL MANAGEMENT
Undoubtedly, the development of pancreatic parenchymal and/or extrapancreatic
necrosis is the critical feature determining the prognosis ofacute pancreatitis. For an early
assessment ofthe severity of acute pancreatitis, blood parameters that are simple to deter-
mine and reliable, such as C-reactive protein, PMN-elastase and serum phospholipase A2
catalytic activity, have been shown to have high accuracy rates for the detection of pan-
creatic necrosis in morphologically well-defined patient populations suffering from acute
pancreatitis [25, 28]. Today CT scanning [29] can therefore be restricted to cases with
high levels ofnecrosis indicating parameters, in dealing with special questions, such as the
evaluation of the intra- and extrapancreatic extent of necrosis.
There is no question that patients with proven severe acute pancreatitis should be
treated in an intensive care unit, as the early phase ofthe disease is characterized by organ
complications such as shock, lung and kidney failure caused by the release of vasoactive
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and organ complications can be successfully treated with intensive care measures alone
and surgery can thus be avoided [30]. Intensive care treatment comprises specific forms
oftherapy to improve pulmonary, renal and cardiocirculatory dysfunction (Table 2).
Table 2. ICU treatment ofsevere acute pancreatitis
Parameters Treatment
Pulmonary insufficiency
Renal insufficiency
Cardiocirculatory
dysfunction/shock
paO2 < 70 mm Hg
paO2 < 60 mm Hg under oxygen
serum creatinine > 120 pmol/l,
urine volume < 30 ml/h
BUN > 30 mmol/l or serum
creatinine > 400 pmol/l
central venous pressurel,
mean arterial pressure < 70 mm Hg
oxygen supply
mechanical ventilation
dopamine (low dose) +
diuretics
hemofiltration,
hemodialysis
volume replacement
dopamine (high dose)
systolic blood pressure
<9OmmHg> 10min
Swan-Ganz catheter
norepinephrine
hyperglycemia > 11.1 mmol/l,
disseminated intravascular
coagulation
Sepsis rectal temperature > 38.5°C,
leukocytes < 4,000/> 12,000/mm3,
platelets < 150,000/mm3
metabolic acidosis > - 4 mmol/l
Infected pancreatic necrosis fine needle aspiration
insulin
fresh frozen plasma
antibiotics, surgical
intervention (FNP+)*
surgery (FNP+)*
Biliary pancreatitis
(BilirubinT, ASATI,
Alk. Phosphataset)
endoscopic retrograde
cholangiography (ERC/ERCP)
papillotomy for impacted
stones
*FNP+ = Fine needle puncture and proof of infection by Gram stain or culture.
From a clinical point of view, surgical management is indicated in patients with
necrotizing pancreatitis who develop signs of septic complications caused by the bacteri-
al infection of necroses, primarily by gram negative germs from the intestinal flora, such
as Escherichia coli, Pseudomonas, Streptococcusfaecalis, etc. The overall infection rate
ofthe necrotic material is approximately 40 - 70 percent in the first 10 days ofthe disease
[5, 31, 32]. Patients with proven infected necroses (fine needle aspiration guided by imag-
ing procedures) and sepsis are candidates for surgical intervention. Patients with focal or
minor necroses have a moderate clinical presentation, and will therefore respond to con-
servative therapy [30]. Persistent organ failure, such as pulmonary and/or renal insuffi-
ciency are indications for surgical therapy, if these complications deteriorate over a peri-
od ofat least 3 - 5 days ofmaximum intensive care treatment (Table 3). Assessment of the
nonresponse of the local and systemic organ complications to conservative therapy is a
very important interdisciplinary step, and forms the basis for the decision to apply surgery.
Metabolic disorders
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Table 3. Indications for surgery in severe acute pancreatitis (1995).
Sepsis Infected pancreatic necrosis (FNP +)*
Multiple organ failure Nonresponse to maximum ICU care measures
(Pulmonary, renal, and
cardiocirculatory insufficiency)
*FNP+: Fine needle puncture and proofof infection by Gram stain or culture
However, it seems more and more evident that the later indication for surgery in severe
acute pancreatitis is necessary in a decreasing minority in the future due to improvements
in intensive care therapy and appropriate antibiotic treatment. Taking into account find-
ings from microbiological data [5, 33] and an Italian multicenter study [34] with early
antibiotic treatment in proven necrotizing pancreatitis we have developed a new treatment
concept (Figure 1). All patients with acute necrotizing pancreatitis are treated in the ICU
and receive Imipenem (cilistatin-Na) therapy over at least 14 days. In case ofclinical signs
of sepsis patients underwent fine needle aspiration with Gram staining and culture. If
infected pancreatic necroses are verified by this examination the indication for surgical
intervention is given.
Algorithm in Acute Pancreatitis
diagnosis:
acute pancreatitis history
p-enzymes
CRP
LDH staging severelnecrotizing AP
_ 'CU
mild/edematous AP
antibiotics
sepsis _ FNP |
surgery
Figure 1. Algorithm for clinical decision-making in acute pancreatitis (AP).
TIMING OF SURGERY
Surgical treatment ofnecrotizing pancreatitis is based on an exhaustive application of
conservative intensive care measures. The timing of surgical intervention in severe acute
pancreatitis is still a matter for discussion. The intervention can be performed "early", that
is in the acute phase, ifcomplications arise which make an early operation absolutely nec-
essary [35, 36] or if the diagnosis is still uncertain [37], but the intervention may also be
"delayed" [38]. The rationale for the concept ofdelaying surgical therapy is that a certain
amount of time must elapse before demarcation of the necroses occurs. However, the
demarcation process cannot yet be evaluated objectively. Furthermore, there are no suffi-
ciently objective data available on the response to conservative therapy and the efficiency
of maximum intensive care treatment protocols (e.g., long-term artificial respiration or
hemofiltration); however, aminimum period ofintensive care therapy should be observed.
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Early operative intervention in the first week of the disease is indicated only in proven
early bacterial infection of the necroses or in non-responders to ICU therapy. Whenever
possible surgical intervention should be delayed in our experience to obtain optimal sur-
gical conditions for necrosectomy.
TECHNIQUES OF SURGICAL TREATMENT
Surgical treatment of necrotizing pancreatitis centers on the removal of the necroses
and the continuous evacuation of necroses and pancreatic fluids, which may contain bac-
terial and biologically active material. Thus, peritoneal dialysis [16, 16, 17] alone cannot
be considered to be an adequate therapy for acute pancreatitis, as has been demonstrated
by Mayer et al. [1 7]. In this study, hospital mortality was the same in the control group
and in the group treated with peritoneal dialysis (27 percent and 28 percent, respectively).
The results ofcurrent clinical studies show that neither can a significant decrease in organ
complications and in the mortality rate be achieved, nor is it to be expected, since the
effects of peritoneal lavage are restricted to the abdominal cavity and have no influence
on the persistent necrotizing process in the retroperitoneal spaces. This therapeutic
approach does not provide for an evacuation of necrotic or bacterially infected tissue.
The exclusively operative implantation of several thick drainage tubes into the lesser
sac, in combination with bile duct drainage (cholecystectomy plus T-drainage), gastrosto-
my andjejunostomy is only partly successful, as necrosectomy is lacking. The aim ofthis
treatment form, known as triple tube drainage [18] and applied mostly in hospitals in the
USA from 1970 onwards, is drainage ofascitic fluid from the lesser sac, and inhibition of
the exocrine pancreatic secretion. Application ofthis surgical procedure has shown, how-
ever, that it does not lead to a substantial reduction in morbidity or mortality. As necroses
and bacterially infected intra-and retropancratic inflammatory necroses are not removed,
it is not surprising that pancreatic abscesses develop at a frequency of up to 40 percent
after application of this triple tube drainage [39].
The aim of surgical treatment of necrotizing pancreatitis with the classical resection
techniques - hemipancreatectomy, partial or total pancreaticoduodenectomy - is total
removal of the diseased pancreatic tissue or the whole organ [13, 14]. Partial or total
pancreatico-duodenectomy also requires the removal of healthy organs (duodenum, parts
of the stomach, extrapancreatic ducts) and this imposes additional stress on the severely
ill patient. Furthermore, surgeons must be aware that in quite a number of cases with
necrotizing pancreatitis only the external parts of the pancreas are necrotic, the pancrea-
tic parenchyma around the pancreatic duct being intact. This type, known as superficial
necrotizing pancreatitis, can easily be mistaken by the surgeon for total necrosis of the
gland, leading to a wrong kind of treatment [10] if he is unaware of the overall morphol-
ogy, as may be seen from a contrast-enhanced CT-scan of the pancreas. Except for the
very rare cases of total pancreatic necrosis, pancreatic resection involves the risk of
overtreatment and increases late morbidity and mortality mainly due to endocrine and
exocrine insufficiency.
Since lavage or drainage of the retroperitoneum alone have been proved unable to
bring down the high morbidity and mortality rates in necrotizing pancreatitis, other surgi-
cal principles, combined with debridement of necroses, were introduced. In the Mayo
series, published by Becker et al. [40] in 1984, hospital mortality rate ofpatients with pan-
creatic abscesses was 40 percent, and the reoperation rate 31 percent. The authors were
dissatisfied with these results, feeling that surgical necrosectomy with drainage alone was
insufficient to achieve a significant reduction ofmortality. Therefore, additional treatment
protocols following surgical debridement were developed. These surgical modalities com-
prise the closed continuous local lavage of necrotic cavities [4, 20], multiple sump
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drainage with lavage or planned frequent reoperations with or without a zipper [21] and
the application of open packing with multiple redressing [22]. Multiple redressings and
frequent reoperation remove the necroses and are carried out in combination with intra-
operative lavage. The Boston series, reported by Warshaw [39], showed a significant
decrease in hospital mortality in patients with necrotizing pancreatitis or pancreatic
abscesses. The overall hospital mortality in the Boston series was 24 percent; in a later
period, only 1 out of 19 patients died. In Atlanta, the open packing technique was applied
exclusively [22]. Multiple redressings, however, entail many reoperations, a prolonged
intensive care phase, and enormous additional stress for the patient. Multiple reoperations
are also the cause of an increased occurrence of intestinal fistulae, stomach outlet
stenoses, mechanical ileus, incisional hernias, and complications with severe local bleed-
ing.
More recently, interventional techniques for the nonoperative management of necro-
tizing pancreatitis have been introduced. Good results were reported with large drainage
tubes placed percutaneously into the necrotic areas [23, 24], using imaging procedures
and avoiding surgical intervention completely. So far experience gained with this new
treatment protocol has been limited, however, and this method obviously cannot guaran-
tee total removal of infected necrotic areas. Every second patient in the series of van
Sonnenberg et al. [41] had to be operated on after drainage, since the removal of necrotic
tissue and the bacterially infected necroses was not complete.
BERNE PROTOCOL OF SURGICAL MANAGEMENT: NECROSECTOMY
AND CLOSED CONTINUOUS LAVAGE OF THE RETROPERITONEUM
The recommended standard technique of surgical management of necrotizing pan-
creatitis is the careful removal of necrotic tissue (necrosectomy) and drainage/lavage of
bacterially infected areas. For this postoperative therapeutic concept three comparable
procedures are available today, the closed continuous lavage [4, 20], the management of
planned, staged relaparotomies [21] and the open packing technique [22]. Hospital mor-
tality in severe acute pancreatitis has been reduced to less than 15 percent with these pro-
cedures in experienced hands.
For the treatment ofpancreatic necroses we perform necrosectomy supplemented by
intraoperative and postoperative closed continuous local lavage ofthe lesser sac and ofthe
necrotic cavities involved in the retroperitoneum. This enables a non-traumatic and con-
tinuous evacuation of devitalized necrotic tissue as well as removal of infected necrotic
tissue and biologically active substances from the ongoing necrotizing process after necro-
sectomy. This procedure has been introduced into our clinical routine with great success.
Necrosectomy and lavage ofthe retroperitoneum
After opening the abdominal cavity, in most patients via an upper abdominal midline
incision, the gastrocolic and duodenocolic ligaments are divided, and the pancreas is
exposed. The extent of necroses in the head, body and tail of the gland can easily be
assessed and measured. Debridement or necrosectomy, either digital or with the careful
use ofinstruments, permits the exclusive removal ofall demarcated devitalized tissue, pre-
serving the vital pancreatic parenchymal tissue. After surgical debridement thorough
hemostasis with transfixion stitches, using monofilament suture material is mandatory. It
has become clear that it is not necessary to remove every gram of devitalized tissue,
because any necrotic or necrotizing tissue is washed out by the lavage fluid later on. After
surgical debridement and suturing of bleeding vessels, extensive intraoperative lavage is
performed, using equal or more than 6 liters ofnormal saline solution, in order to clear the
surface of the pancreatic and peripancreatic tissues. For postoperative closed continuous
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local lavage (the necrotizing process is ofcourse still going on) two or more double-lumen
Salem sump tubes (20-24 Ch) and single-lumen silicone rubber tubes (28 - 32 Ch) are
inserted, so that at least a regionally restricted lavage is effected. The gastrocolic and duo-
denocolic ligaments are sutured again to create a closed retroperitoneal lesser sac com-
partment for the postoperative continuous lavage. In the first seven postoperative days, the
amount of lavage fluid is 35-40 liters with rapid reduction during the following days,
depending on the clinical course and appearance ofthe outflowing fluid (in regular inter-
vals measurement of pancreatic enzymes and bacteriological examinations). For the
lavage a slightly hyper-osmotic fluid is used, mostly the normal continuous ambulatory
peritoneal dialysis solution. The drainage tubes are removed successively within 2-3
weeks.
From November 1993 to September 1995 a total of64 patients with acute pancreati-
tis were admitted to our University Hospital ofBerne. Due to indicators ofnecrosis (CRP
> 120 mg/I) 32 patients suffered from acute necrotizing pancreatitis proven by contrast-
enhanced CT. All patients with proven necrotizing pancreatitis received Imipenem (cilas-
tatin-Na) therapy over at least 14 days in adosage of3 x 0.5 g/day. In case ofclinical signs
of sepsis patients underwent fine needle-aspiration with Gram staining and culture. All
patients with acute necrotizing pancreatitis were treated in the ICU with maximum con-
servative therapy measures. In 1 1/32 patients (34 percent) infected pancreatic necrosis
were found by fine needle aspiration analysis (E. coli, Enterococcus, Staphylococcus
aureus, Klebsiella and Candida) after a mean of 21 ± 3.3 days after the onset of the dis-
ease leading to a delayed surgical intervention in these patients. The surgical group (n =
I 1) was treated with necrosectomy and closed retroperitoneal lavage over a mean of23 +
7.8 days. One patient developed an abscess which was successfully managed by an inter-
ventional approach. No other reinterventions were necessary. The mean total length of
hospital stay in sterile and infected acute necrotizing pancreatitis were 25 ± 8.9 and 65 ±
13.5 days, respectively. Mortality rates were 9 percent (1/11) and 0 percent (0/21) in
infected and sterile acute necrotizing pancreatitis, respectively.
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